REG1A and diabetes mellitus: Disruption of murine Reg1 (the ortholog of rat Reg1a) resulted in decreased proliferative capacity of pancreatic beta cells [44], whereas administration of recombinant rat Reg1a resulted in beta-cell regeneration and reversal of diabetes in rats after surgical resection of 90% of the pancreas [19].